Details for Patent: 6,110,900

Title:	Nucleic acid ligands
Abstract:	This invention comprises nucleic acid ligand for use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample, and a diagnostic reagent to measure the amount of a target molecule in a sample. In a preferred embodiment the nucleic acid ligands are identified by the method of the invention referred to as the Systematic Evolution of Ligands by EXponential enrichment (SELEX), wherein a candidate mixture of nucleic acids are iteratively enriched in high affinity nucleic acids and amplified by further partitioning.
Inventor(s):	Gold; Larry (Boulder, CO), Tuerk; Craig (Morehead, KY)
Assignee:	NeXstar Pharmaceuticals, Inc. (Boulder, CO)
Filing Date:	Aug 27, 1998
Application Number:	09/143,190
Claims:	1. A diagnostic composition comprising a nucleic acid ligand. 2. The diagnostic composition of claim 1 wherein said nucleic acid ligand is single-stranded. 3. The diagnostic composition of claim 2 wherein said nucleic acid ligand is ribonucleic acid. 4. The diagnostic composition of claim 2 wherein said nucleic acid ligand is deoxyribonucleic acid. 5. The diagnostic composition of claim 1 wherein said nucleic acid ligand is labeled. 6. The diagnostic composition of claim 5 wherein said label is a radiolabel. 7. The diagnostic composition of claim 1 wherein said nucleic acid ligand binds to a target molecule that is a protein. 8. The diagnostic composition of claim 7 wherein said protein is not known to bind nucleic acids as part of its biological function. 9. The diagnostic composition of claim 1 wherein said nucleic acid ligand binds to a target molecule that is a small molecule. 10. The diagnostic composition of claim 1 wherein said nucleic acid ligand binds to a target molecule that is a controlled substance. 11. The diagnostic composition of claim 1 wherein said nucleic acid ligand binds to a target molecule that is a metabolite. 12. The diagnostic composition to claim 1 wherein said nucleic acid ligand binds to a target molecule that is a biological substance. 13. A diagnostic composition comprising a nucleic acid ligand to a target molecule, said nucleic acid ligand being identified from a candidate mixture of nucleic acids by a method comprising: (a) contacting the candidate mixture with said target molecule, wherein nucleic acids having an increased affinity to said target molecule relative to the candidate mixture may be partitioned from the remainder of the candidate mixture; (b) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; and (c) amplifying the increased affinity nucleic acids to yield a ligand-enriched mixture of nucleic acids, wherein an increased affinity nucleic acid ligand may be identified. 14. The diagnostic composition of claim 13 wherein said nucleic acid ligand is identified after repeating steps (a), (b) and (c) at least once. 15. The diagnostic composition of claim 13 wherein the nucleic acid ligand is single-stranded. 16. The diagnostic composition of claim 15 wherein the nucleic acid ligand is ribonucleic acid. 17. The diagnostic composition of claim 15 wherein the nucleic acid is deoxyribonucleic acid. 18. The diagnostic composition of claim 13 wherein the target molecule is a protein. 19. The diagnostic composition of claim 18 wherein said protein is not known to bind nucleic acids as part of its biological function. 20. The diagnostic composition of claim 13 wherein said target molecule is a controlled substance. 21. The diagnostic composition of claim 13 wherein said target molecule is a metabolite. 22. The diagnostic composition of claim 13 wherein said target molecule is a small molecule. 23. The diagnostic composition of claim 13 wherein said candidate mixture is prepared by synthesis from a template comprising a region of conserved sequence and a region of randomized and/or biased sequence.